Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
Weidong Li, Xuesong Dong, Changjun He, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 167

Showing 1-25 of 167 citing articles:

The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
Weiwei Tang, Ziyi Chen, Wenling Zhang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 770
Long Non-Coding RNA in the Pathogenesis of Cancers
Yujing Chi, Di Wang, Junpei Wang, et al.
Cells (2019) Vol. 8, Iss. 9, pp. 1015-1015
Open Access | Times Cited: 708
Long non-coding RNAs: From disease code to drug role
Yuanyuan Chen, Zhaojun Li, Xiaoguang Chen, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 2, pp. 340-354
Open Access | Times Cited: 378
Molecular Bases of Drug Resistance in Hepatocellular Carcinoma
José J.G. Marı́n, Rocı́o I.R. Macı́as, María J. Monte, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1663-1663
Open Access | Times Cited: 156
Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC
Yau-Tuen Chan, Junyu Wu, Yuanjun Lu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARα-mediated fatty acid oxidation
Chunxiao Li, Liting Xiong, Yuhan Yang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
An Emerging Class of Long Non-coding RNA With Oncogenic Role Arises From the snoRNA Host Genes
Alina‐Andreea Zimța, Adrian Bogdan Țigu, Cornelia Braicu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 136
Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs
Wenxiao Jiang, Jun Xia, Shangdan Xie, et al.
Drug Resistance Updates (2020) Vol. 50, pp. 100683-100683
Closed Access | Times Cited: 115
PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma
Yuting Wu, Yingshi Zhang, Xiaochun Qin, et al.
Pharmacological Research (2020) Vol. 160, pp. 105195-105195
Closed Access | Times Cited: 109
Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications
Huibin Song, Dongcheng Liu, Shaowei Dong, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 104
LncRNA NEAT1 promotes autophagy via regulating miR‐204/ATG3 and enhanced cell resistance to sorafenib in hepatocellular carcinoma
Xinyu Li, Yong Zhou, Liang Yang, et al.
Journal of Cellular Physiology (2019) Vol. 235, Iss. 4, pp. 3402-3413
Closed Access | Times Cited: 102
LncRNA AC099850.3 promotes hepatocellular carcinoma proliferation and invasion through PRR11/PI3K/AKT axis and is associated with patients prognosis
Fang-Jing Zhong, Sheng Liu, Donghai Hu, et al.
Journal of Cancer (2022) Vol. 13, Iss. 3, pp. 1048-1060
Open Access | Times Cited: 44
Silencing lncRNA HCG18 regulates GPX4-inhibited ferroptosis by adsorbing miR-450b-5p to avert sorafenib resistance in hepatocellular carcinoma
X. Li, Yunhui Li, Peilong Lian, et al.
Human & Experimental Toxicology (2023) Vol. 42
Open Access | Times Cited: 37
Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
Lei Jiang, Luan Li, Yongzhuang Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 31
The Roles of Epigenetic Regulation and the Tumor Microenvironment in the Mechanism of Resistance to Systemic Therapy in Hepatocellular Carcinoma
Kyoko Oura, Asahiro Morishita, Sae Hamaya, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2805-2805
Open Access | Times Cited: 25
WTAP-mediated m6A modification of lncRNA Snhg1 improves myocardial ischemia-reperfusion injury via miR-361-5p/OPA1-dependent mitochondrial fusion
Linlin Liu, Jiahong Wu, Cheng Lü, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
microRNA 21 and long non-coding RNAs interplays underlie cancer pathophysiology: A narrative review
Roberta Giordo, Fatemeh Abdullah M. Ahmadi, Nedal Al Husaini, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 3, pp. 831-852
Open Access | Times Cited: 9
Spatial‒temporal heterogeneities of liver cancer and the discovery of the invasive zone
Jiayan Yan, Zhifeng Jiang, Shiyu Zhang, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access | Times Cited: 1
Long non‐coding small nucleolar RNA host genes in digestive cancers
Huan Yang, Zheng Jiang, Shuang Wang, et al.
Cancer Medicine (2019) Vol. 8, Iss. 18, pp. 7693-7704
Open Access | Times Cited: 70
MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, et al.
European Journal of Pharmacology (2020) Vol. 892, pp. 173660-173660
Closed Access | Times Cited: 68
Autophagy-related microRNAs: Possible regulatory roles and therapeutic potential in and gastrointestinal cancers
Mohammad Hossein Pourhanifeh, Massoud Vosough, Maryam Mahjoubin‐Tehran, et al.
Pharmacological Research (2020) Vol. 161, pp. 105133-105133
Closed Access | Times Cited: 62
<p>Long Noncoding RNA HCP5 Regulates Pancreatic Cancer Gemcitabine (GEM) Resistance By Sponging Hsa-miR-214-3p To Target HDGF</p>
Yunfei Liu, Jiale Wang, Dong Luo, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 8207-8216
Open Access | Times Cited: 57
Endoplasmic reticulum stress confers 5-fluorouracil resistance in breast cancer cell via the GRP78/OCT4/lncRNA MIAT/AKT pathway.
Xiaoli Yao, Yi Tu, Yulin Xu, et al.
PubMed (2020) Vol. 10, Iss. 3, pp. 838-855
Closed Access | Times Cited: 51
Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N6-methyladenosine of PARP1 mRNA and downregulating PTEN
Lei Yang, Yi Chen, Ning Liu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 49
Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights
Xinchen Tian, Tinghao Yan, Fen Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top